AAAAAA

   
Results: 1-10 |
Results: 10
EXTRACORPOREAL SHOCK-WAVE LITHOTRIPSY AS FIRST LINE MONOTHERAPY OF SOLITARY CALYCEAL CALCULI
Authors: ANDREASSEN KH DAHL C ANDERSEN JT RASMUSSEN MS JACOBSEN JD MOGENSEN P
Citation: Kh. Andreassen et al., EXTRACORPOREAL SHOCK-WAVE LITHOTRIPSY AS FIRST LINE MONOTHERAPY OF SOLITARY CALYCEAL CALCULI, Scandinavian journal of urology and nephrology, 31(3), 1997, pp. 245-248
ESTRAMUSTINE PHOSPHATE VERSUS PLACEBO AS 2ND LINE TREATMENT AFTER ORCHIECTOMY IN PATIENTS WITH METASTATIC PROSTATE-CANCER - DAPROCA STUDY-9002
Authors: IVERSEN P RASMUSSEN F ASMUSSEN C CHRISTENSEN IJ EICKHOFF J KLARSKOV P LARSEN E MOGENSEN P MOMMSEN S ROSENKILDE P
Citation: P. Iversen et al., ESTRAMUSTINE PHOSPHATE VERSUS PLACEBO AS 2ND LINE TREATMENT AFTER ORCHIECTOMY IN PATIENTS WITH METASTATIC PROSTATE-CANCER - DAPROCA STUDY-9002, The Journal of urology, 157(3), 1997, pp. 929-934
PLACEBO-EFFECTS IN THE PHARMACOLOGICAL TREATMENT OF UNCOMPLICATED BENIGN PROSTATIC HYPERPLASIA
Authors: HANSEN BJ MEYHOFF HH NORDLING J MENSINK HJA MOGENSEN P LARSEN EH LEENARTS JAF OOSTEN JK VANSOEST FF DIJKMAN GA HOEKSTRA JW VANBAASBANK NJW BIJLEVELD RT BRAAM PFCM SCHLATMANN TJM FELDERHOF J KAPPER BJ DIK P SCHOU J POULSEN AL CHRISTOFFERSEN J GEERDSEN JP HVIDT V DAHL C LUKE M LENDORPH A JACOBSEN B BILDE T MORTENSEN S WALTER S
Citation: Bj. Hansen et al., PLACEBO-EFFECTS IN THE PHARMACOLOGICAL TREATMENT OF UNCOMPLICATED BENIGN PROSTATIC HYPERPLASIA, Scandinavian journal of urology and nephrology, 30(5), 1996, pp. 373-377
LONG-TERM PREDICTIVE ROLE OF URODYNAMICS - AN 8-YEAR FOLLOW-UP OF PROSTATIC SURGERY FOR LOWER URINARY-TRACT SYMPTOMS
Authors: JENSEN KME JORGENSEN JB MOGENSEN P
Citation: Kme. Jensen et al., LONG-TERM PREDICTIVE ROLE OF URODYNAMICS - AN 8-YEAR FOLLOW-UP OF PROSTATIC SURGERY FOR LOWER URINARY-TRACT SYMPTOMS, British Journal of Urology, 78(2), 1996, pp. 213-218
CSF AND PLASMA-CONCENTRATIONS OF FREE NOREPINEPHRINE, DOPAMINE, 3,4-DIHYDROXYPHENYLACETIC ACID (DOPAC), 3,4-DIHYDROXYPHENYLALANINE (DOPA), AND EPINEPHRINE IN PARKINSONS-DISEASE
Authors: ELDRUP E MOGENSEN P JACOBSEN J PAKKENBERG H CHRISTENSEN NJ
Citation: E. Eldrup et al., CSF AND PLASMA-CONCENTRATIONS OF FREE NOREPINEPHRINE, DOPAMINE, 3,4-DIHYDROXYPHENYLACETIC ACID (DOPAC), 3,4-DIHYDROXYPHENYLALANINE (DOPA), AND EPINEPHRINE IN PARKINSONS-DISEASE, Acta neurologica Scandinavica, 92(2), 1995, pp. 116-121
LONG-TERM PROBABILITY OF PROSTATISM VS GENERAL MORBIDITY AND MORTALITY - PROSPECTIVELY OBTAINED DATA IN A RANDOMLY SELECTED COHORT AGED GREATER-THAN-50 YEARS
Authors: JORGENSEN JB JENSEN KME MOGENSEN P
Citation: Jb. Jorgensen et al., LONG-TERM PROBABILITY OF PROSTATISM VS GENERAL MORBIDITY AND MORTALITY - PROSPECTIVELY OBTAINED DATA IN A RANDOMLY SELECTED COHORT AGED GREATER-THAN-50 YEARS, Scandinavian journal of urology and nephrology, 28(2), 1994, pp. 163-169
PRIMARY IN-SITU EXTRACORPOREAL SHOCK-WAVE LITHOTRIPSY FOR URETERAL CALCULI
Authors: MOGENSEN P ANDERSEN JT
Citation: P. Mogensen et Jt. Andersen, PRIMARY IN-SITU EXTRACORPOREAL SHOCK-WAVE LITHOTRIPSY FOR URETERAL CALCULI, Scandinavian journal of urology and nephrology, 1994, pp. 159-163
LONG-TERM RESULTS OF DANISH-PROSTATIC-CANCER-GROUP TRIAL-86
Authors: IVERSEN P RASMUSSEN F KLARSKOV P CHRISTENSEN IJ CHRISTENSEN MG FRIIS E HORNBOL P HVIDT V MOGENSEN P IVERSEN HG ROSE C KRARUP T LUND F PEDERSEN T SKAARUP P WOLF H
Citation: P. Iversen et al., LONG-TERM RESULTS OF DANISH-PROSTATIC-CANCER-GROUP TRIAL-86, Cancer, 72(12), 1993, pp. 3851-3854
LONGITUDINAL OBSERVATIONS ON NORMAL AND ABNORMAL VOIDING IN MEN OVER THE AGE OF 50 YEARS
Authors: JORGENSEN JB JENSEN KME MOGENSEN P
Citation: Jb. Jorgensen et al., LONGITUDINAL OBSERVATIONS ON NORMAL AND ABNORMAL VOIDING IN MEN OVER THE AGE OF 50 YEARS, British Journal of Urology, 72(4), 1993, pp. 413-420
CSCW CHALLENGES - COOPERATIVE DESIGN IN ENGINEERING PROJECTS
Authors: GRONBAEK K KYNG M MOGENSEN P
Citation: K. Gronbaek et al., CSCW CHALLENGES - COOPERATIVE DESIGN IN ENGINEERING PROJECTS, Communications of the ACM, 36(6), 1993, pp. 67-77
Risultati: 1-10 |